MRSA-surveillance in Germany: data from the Antibiotic Resistance Surveillance System (ARS) and the mandatory surveillance of MRSA in blood

  • B. SchweickertEmail author
  • I. Noll
  • M. Feig
  • H. Claus
  • G. Krause
  • E. Velasco
  • T. Eckmanns


Data from the German Antibiotic Resistance Surveillance system (ARS) and statutory notification of methicillin-resistant Staphylococcus aureus (MRSA) in blood cultures are presented. ARS is a voluntary laboratory-based surveillance system providing resistance data of all clinical pathogens and sample types from hospitals and ambulatory care. Statutory notification includes MRSA detected in blood and cerebrospinal fluid by microbiological laboratories. Resistance data from 2008 to 2010 and MRSA-bacteraemia incidences from 2010 are presented. From 2008 to 2010, resistance data from 70,935 Staphylococcus aureus isolates were transferred to the national health institution. MRSA proportions in hospitals and outpatient care account for 19.2% and 10.6%, respectively. In hospital care high proportions of MRSA were found in nephrological, geriatric, neurological general wards and surgical ICUs (49.4%, 45.8%, 34.2%, and 27.0%, respectively), while in community outpatient care urological practices (29.2%) account for the highest values. In both healthcare settings urinary tract samples stand out with high proportions of MRSA (hospitals, 32.9%; outpatients, 20.5%). In 2010, 3900 cases of MRSA bacteraemia were reported, accounting for an incidence of MRSA bacteraemia of 4.8/100,000 inhabitants/year. Stratification by federal states shows considerable regional differences (range, 1.0–8.3/100,000 inhabitants/year). Vulnerable areas in hospitals and outpatient care have been pointed out as subjects for further inquiries.


Outpatient Care General Ward Infection Control Measure Robert Koch Institute Surgical ICUs 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank the ARS laboratories for the provision of resistance data thereby contributing essentially to the presented results: Gemeinschaftspraxis für Laboratoriumsmedizin GbR - Labor Plön, Institut für Hygiene und Medizinische Mikrobiologie Universitätsklinikum Heidelberg; Institut für Infektionsmedizin Universitätsklinikum Schleswig-Holstein; Labor 28 MVZ Berlin; Labor Dr. Limbach & Kollegen Heidelberg; MVZ Dortmund - Dr. Eberhard & Partner; MVZ Dr. Löer - Dr. Treder und Kollegen, Münster; MVZ Dr. Stein und Kollegen Mönchengladbach; MVZ Wagnerstibbe Göttingen; Institut für Mikrobiologie und Hygiene Universitätsmedizin Charité Berlin.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Chaberny IF, Sohr D, Rüden H, Gastmeier P (2007) Development of a surveillance system for methicillin-resistant Staphylococcus aureus in German hospitals. Infect Control Hosp Epidemiol 28(4):446–452PubMedCrossRefGoogle Scholar
  2. 2.
    Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD (2003) Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 31(4):208–215PubMedGoogle Scholar
  3. 3.
    Daniels-Haardt I, Verhoeven F, Mellmann A, Hendrix MG, Gemert-Pijnen JE, Friedrich AW (2006) EUREGIO-projekt MRSA-net Twente/Münsterland. Creation of a regional network to combat MRSA. Gesundheitswesen 68(11):674–678PubMedCrossRefGoogle Scholar
  4. 4.
    Witte W, Cuny C, Klare I, Nübel U, Strommenger B, Werner G (2008) Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens. Int J Med Microbiol 298(5–6):365–377PubMedCrossRefGoogle Scholar
  5. 5.
    Ministery of Health, Germany (2008) DART, Deutsche Antibiotika-Resistenz-Strategie. Accessed 15 December 2011
  6. 6.
    Tiemersma EW, Bronzwaer SL, Lyytikäinen O, Degener JE, Schrijnemakers P, Bruinsma N, Monen J, Witte W, Grundman H, Participants European Antimicrobial Resistance Surveillance System (2004) Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerg Infect Dis 10(9):1627–1634PubMedCrossRefGoogle Scholar
  7. 7.
    Kohlenberg A, Schwab F, Geffers C, Behnke M, Rüden H, Gastmeier P (2008) Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between 2000 and 2005. Clin Microbiol Infect 14(1):93–96PubMedCrossRefGoogle Scholar
  8. 8.
    European Centre for Disease Prevention and Control (2010) Antimicrobial resistance surveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2009. Accessed 15 December 2011
  9. 9.
    Statens Serum Institut, Danish Veterinary and Food Administration, Danish Medicines Agency, National Veterinary Institute, Technical University of Denmark, National Food Institute, Technical University of Denmark (2010) DANMAP 2009 - Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Accessed 15 December 2011
  10. 10.
    Jacobsson G, Dashti S, Wahlberg T, Andersson R (2007) The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 39(1):6–13PubMedCrossRefGoogle Scholar
  11. 11.
    Health Protection Agency (2010) Mandatory reporting of Staphylococcus aureus Accessed 15 December 2011
  12. 12.
    Laupland KB, Ross T, Gregson DB (2008) Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. J Infect Dis 198(3):336–343PubMedCrossRefGoogle Scholar
  13. 13.
    Lessa FC, Mu Y, Davies J, Murray M, Lillie M, Pearson A, Fridkin SK, Infections E, Program/Active Bacterial Core surveillance MRSA Investigators and the Health Protection Agency Team (2010) Comparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006–2007. Clin Infect Dis 51(8):925–928PubMedCrossRefGoogle Scholar
  14. 14.
    Kerttula AM, Lyytikäinen O, Salmenlinna S, Vuopio-Varkila J (2004) Changing epidemiology of methicillin-resistant Staphylococcus aureus in Finland. J Hosp Infect 58(2):109–114PubMedCrossRefGoogle Scholar
  15. 15.
    Collignon P, Nimmo GR, Gottlieb T, Gosbell IB, Australian Group on Antimicrobial Resistance (2005) Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis 11(4):554–561PubMedCrossRefGoogle Scholar
  16. 16.
    Kern WV (2010) Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. Curr Opin Infect Dis 23(4):346–358PubMedCrossRefGoogle Scholar
  17. 17.
    Collignon PJ, Wilkinson IJ, Gilbert GL, Grayson ML, Whitby RM (2006) Health care-associated Staphylococcus aureus bloodstream infections: a clinical quality indicator for all hospitals. Med J Aust 184(8):404–406PubMedGoogle Scholar
  18. 18.
    Dendle C, Martin RD, Cameron DR, Grabsch EA, Mayall BC, Grayson ML, Johnson PD (2009) Staphylococcus aureus bacteraemia as a quality indicator for hospital infection control. Med J Aust 191(7):389–92PubMedGoogle Scholar
  19. 19.
    Johnson AP, Sharland M, Goodall CM, Blackburn R, Kearns AM, Gilbert R, Lamagni TL, Charlett A, Ganner M, Hill R, Cookson B, Livermore D, Wilson J, Cunney R, Rossney A, Duckworth G (2010) Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Arch Dis Child 95(10):781–5, Erratum in: Arch Dis Child. 2011 Jun;96(6):e1PubMedCrossRefGoogle Scholar
  20. 20.
    Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR 3rd, St Sauver JL, Wilson WR, Baddour LM (2007) Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 167(8):834–839PubMedCrossRefGoogle Scholar
  21. 21.
    Skogberg K, Lyytikäinen O, Ruutu P, Ollgren J, Nuorti JP (2008) Increase in bloodstream infections in Finland, 1995–2002. Epidemiol Infect 136(1):108–114PubMedCrossRefGoogle Scholar
  22. 22.
    Stenhem M, Ortqvist A, Ringberg H, Larsson L, Olsson-Liljequist B, Haeggman S, Ekdahl K, Swedish Group on MRSA Epidemiology (2006) Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences. BMC Infect Dis 6:30PubMedCrossRefGoogle Scholar
  23. 23.
    Asensio A, Cantón R, Vaqué J, Rosselló J, Calbo F, García-Caballero J, Domínguez V, Hernández A, Trilla A, Epine Working Group (2006) Nosocomial and community-acquired methicillin-resistant Staphylococcus aureus infections in hospitalized patients (Spain, 1993–2003). J Hosp Infect 63(4):465–471PubMedCrossRefGoogle Scholar
  24. 24.
    Tiemersma EW, Monnet DL, Bruinsma N, Skov R, Monen JC, Grundmann H (2005) Staphylococcus aureus bacteremia, Europe. Emerg Infect Dis 11(11):1798–1799PubMedCrossRefGoogle Scholar
  25. 25.
    Simonsen GS, Tapsall JW, Allegranzi B, Talbot EA, Lazzari S (2004) The antimicrobial resistance containment and surveillance approach—a public health tool. Bull World Health Organ 82(12):928–934Google Scholar
  26. 26.
    Kanerva M, Ollgren J, Lyytikäinen O, Finnish Prevalence Survey Study Group (2010) Interhospital differences and case-mix in a nationwide prevalence survey. J Hosp Infect 76(2):135–138PubMedCrossRefGoogle Scholar
  27. 27.
    Miller R, Esmail H, Peto T, Walker S, Crook D, Wyllie D (2008) Is MRSA admission bacteraemia community-acquired? A case control study. J Infect 56(3):163–170PubMedCrossRefGoogle Scholar
  28. 28.
    Morin CA, Hadler JL (2001) Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 184(8):1029–1034PubMedCrossRefGoogle Scholar
  29. 29.
    Wyllie DH, Walker AS, Peto TE, Crook DW (2007) Hospital exposure in a UK population, and its association with bacteraemia. J Hosp Infect 67(4):301–307PubMedCrossRefGoogle Scholar
  30. 30.
    O’Connell B, McMahon G, Kelleher M, Rossney AS (2007) Methicillin-resistant Staphylococcus aureus blood-stream infection among patients attending the emergency department of an urban tertiary-referral hospital. Ir Med J 100(4):433–435PubMedGoogle Scholar
  31. 31.
    Fluck R, Wilson J, Tomson CR (2010) UK Renal Registry 12th Annual Report (December 2009): chapter 12: epidemiology of methicillin resistant Staphylococcus aureus bacteraemia amongst patients receiving dialysis for established renal failure in England in 2008: a joint report from the UK Renal Registry and the Health Protection Agency. Nephron Clin Pract 115(Suppl 1):c261–c270PubMedCrossRefGoogle Scholar
  32. 32.
    Grundmann H, Aanensen DM, van den Wijngaard CC, Spratt BG, Harmsen D, Friedrich AW; European Staphylococcal Reference Laboratory Working Group (2010) Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 12;7(1):e1000215.Google Scholar
  33. 33.
    Naber CK (2009) Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis 48(Suppl 4):S231–S237PubMedCrossRefGoogle Scholar
  34. 34.
    Jeyaratnam D, Edgeworth JD, French GL (2006) Enhanced surveillance of methicillin-resistant Staphylococcus aureus bacteraemia in a London teaching hospital. J Hosp Infect 63(4):365–373PubMedCrossRefGoogle Scholar
  35. 35.
    Grundmann H, Hori S, Winter B, Tami A, Austin DJ (2002) Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis 185(4):481–488PubMedCrossRefGoogle Scholar
  36. 36.
    Graffunder EM, Venezia RA (2002) Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49(6):999–1005PubMedCrossRefGoogle Scholar
  37. 37.
    Halwani M, Solaymani-Dodaran M, Grundmann H, Coupland C, Slack R (2006) Cross-transmission of nosocomial pathogens in an adult intensive care unit: incidence and risk factors. J Hosp Infect 63(1):39–46PubMedCrossRefGoogle Scholar
  38. 38.
    Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P (2011) Increasing consumption of MRSA-active drugs without increasing MRSA in German ICUs. Intensive Care Med 37(10):1628–1632PubMedCrossRefGoogle Scholar
  39. 39.
    Geffers C, Gastmeier P (2011) Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System). Dtsch Arztebl Int 108(6):87–93PubMedGoogle Scholar
  40. 40.
    Gastmeier P, Schwab F, Geffers C, Rüden H (2004) To isolate or not to isolate? Analysis of Data from the German Nosocomial Infection surveillance system regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units. Infect Control Hosp Epidemiol 25(2):109–113PubMedCrossRefGoogle Scholar
  41. 41.
    Routh JC, Alt AL, Ashley RA, Kramer SA, Boyce TG (2009) Increasing prevalence and associated risk factors for methicillin resistant Staphylococcus aureus bacteriuria. J Urol 181(4):1694–1698PubMedCrossRefGoogle Scholar
  42. 42.
    Gastmeier P, Behnke M, Schwab F, Geffers C. (2011) Benchmarking of urinary tract infection rates: experiences from the intensive care unit component of the German national nosocomial infections surveillance system. J Hosp Infect 78(1):41–44Google Scholar
  43. 43.
    Lietzau S, Stürmer T, Erb A, Von Baum H, Marre R, Brenner H (2004) Prevalence and determinants of nasal colonization with antibiotic-resistant Staphylococcus aureus among unselected patients attending general practitioners in Germany. Epidemiol Infect 132(4):655–662PubMedCrossRefGoogle Scholar
  44. 44.
    Barnett BJ, Stephens DS (1997) Urinary tract infection: an overview. Am J Med Sci 314(4):245–249PubMedCrossRefGoogle Scholar
  45. 45.
    Andrews WW, Schelonka R, Waites K, Stamm A, Cliver SP, Moser S (2008) Genital tract methicillin-resistant Staphylococcus aureus: risk of vertical transmission in pregnant women. Obstet Gynecol 111(1):113–118PubMedCrossRefGoogle Scholar
  46. 46.
    Daeschlein G, Assadian O, Rangous I, Kramer A (2006) Risk factors for Staphylococcus aureus nasal carriage in residents of three nursing homes in Germany. J Hosp Infect 63(2):216–220PubMedCrossRefGoogle Scholar
  47. 47.
    Jappe U, Heuck D, Strommenger B, Wendt C, Werner G, Altmann D, Witte W (2008) Staphylococcus aureus in dermatology outpatients with special emphasis on community-associated methicillin-resistant strains. J Invest Dermatol 128(11):2655–2664PubMedCrossRefGoogle Scholar
  48. 48.
    Schweickert B, Geffers C, Farragher T, Gastmeier P, Behnke M, Eckmanns T, Schwab F (2011) The MRSA-import in ICUs is an important predictor for the occurrence of nosocomial MRSA cases. Clin Microbiol Infect 17(6):901–906PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • B. Schweickert
    • 1
    Email author
  • I. Noll
    • 1
  • M. Feig
    • 1
  • H. Claus
    • 1
  • G. Krause
    • 1
  • E. Velasco
    • 1
  • T. Eckmanns
    • 1
  1. 1.Robert Koch InstitutBerlinGermany

Personalised recommendations